Echle, A, Grabsch, HI orcid.org/0000-0001-9520-6228, Quirke, P orcid.org/0000-0002-3597-5444 et al. (20 more authors) (2020) Clinical-grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning. Gastroenterology, 159 (4). 1406-1416.e11. ISSN 0016-5085
Abstract
Background and Aims: Microsatellite instability (MSI) and mismatch-repair deficiency (dMMR) in colorectal tumors are used to select treatment for patients. Deep learning can detect MSI and dMMR in tumor samples on routine histology slides faster and cheaper than molecular assays. But clinical application of this technology requires high performance and multisite validation, which have not yet been performed.
Methods: We collected hematoxylin and eosin-stained slides, and findings from molecular analyses for MSI and dMMR, from 8836 colorectal tumors (of all stages) included in the MSIDETECT consortium study, from Germany, the Netherlands, the United Kingdom, and the United States. Specimens with dMMR were identified by immunohistochemistry analyses of tissue microarrays for loss of MLH1, MSH2, MSH6, and/or PMS2. Specimens with MSI were identified by genetic analyses. We trained a deep-learning detector to identify samples with MSI from these slides; performance was assessed by cross-validation (n=6406 specimens) and validated in an external cohort (n=771 specimens). Prespecified endpoints were area under the receiver operating characteristic (AUROC) curve and area under the precision-recall curve (AUPRC).
Results: The deep-learning detector identified specimens with dMMR or MSI with a mean AUROC curve of 0.92 (lower bound 0.91, upper bound 0.93) and an AUPRC of 0.63 (range, 0.59–0.65), or 67% specificity and 95% sensitivity, in the cross-validation development cohort. In the validation cohort, the classifier identified samples with dMMR with an AUROC curve of 0.95 (range, 0.92–0.96) without image-preprocessing and an AUROC curve of 0.96 (range, 0.93–0.98) after color normalization.
Conclusions: We developed a deep-learning system that detects colorectal cancer specimens with dMMR or MSI using hematoxylin and eosin-stained slides; it detected tissues with dMMR with an AUROC of 0.96 in a large, international validation cohort. This system might be used for high-throughput, low-cost evaluation of colorectal tissue specimens.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2020 by the AGA Institute. Published by Elsevier Inc. This is an openaccess article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
Keywords: | Biomarker; cancer immunotherapy; Lynch syndrome; mutation |
Dates: |
|
Institution: | The University of Leeds |
Funding Information: | Funder Grant number Yorkshire Cancer Research L394 Yorkshire Cancer Research L386 NIHR National Inst Health Research No Ext Ref |
Depositing User: | Symplectic Publications |
Date Deposited: | 10 Jun 2020 09:58 |
Last Modified: | 25 Jun 2023 22:18 |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1053/j.gastro.2020.06.021 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:161715 |